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Abstract
This study aimed to investigate possible asymmetries and relationships between performance of dominant and non-dominant
upper limbs (UL) in patients with Duchenne and Becker muscular dystrophies (DMD/BMD), to compare UL performance of
patients and healthy subjects and to investigate the relationship between timed performance of UL and age, motor function
and muscle strength in DMD/BMD patients. Sixteen patients with DMD and 3 with BMD were evaluated with Jebsen-Taylor
Test (timed performance), Vignos scale and Dimension 3 of Motor Function Measure (motor function), and Medical Research
Council scale (muscle strength) on a single session. ANOVA showed no asymmetry between dominant and non-dominant UL,
except in the writing subtest, in patients and in healthy controls. There were relationships between dominant and non-dominant
UL performances. Correlations between timed performance, motor function and muscle strength were found, but age was not
correlated with these variables. These findings may reduce the assessment time, prevent fatigue and provide more accurate
clinical reasoning involving UL in DMD/BMD treatment.
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Introduction
The recent increase of life expectancy of patients with
Duchenne and Becker muscular dystrophies (DMD and
BMD) represents more patients living with impaired upper
limb (UL) function for longer times (1). DMD and BMD are
related conditions that affect skeletal muscles. They occur
almost exclusively in males and have similar signs and
symptoms that are caused by different mutations in the
same gene. Because DMD and BMD result from faulty
or missing dystrophin, these conditions are classified as
dystrophinopathies.
DMD and BMD may differ in severity, age of onset and
rate of progression. In DMD, muscle weakness tends to
decrease faster. DMD and BMD together affect 1 in 3500
to 5000 newborn males worldwide. Both show proximal-
to-distal progression, with relative sparing of distal hand
function (2). Losses of hand and wrist functions occur mainly
in advanced stages (3,4). Due to the progressive nature
of DMD/BMD, upper extremity weakness and limitations
impair the ability of performing daily life activities, including
eating, bathing, and tooth brushing (2,5).
Assessing UL function in non-ambulant patients with
DMD/BMD is challenging, because of the combination
of severe weakness, contractures, clinical heterogeneity
and varied compensatory strategies (from patient to patient
and even from limb to limb) (1). Janssen et al. (6) investi-
gated the differences between dominant and non-dominant
UL activity of shoulder and elbow muscles of 5 patients
with DMD. The patients performed single movements of
these joints and the non-standardized tasks of reaching
forward, touching the contralateral shoulder, combing hair
and bringing the hand to the mouth. They found no signifi-
cant differences in shoulder and elbow muscle recruitment
between ULs (6). However, the activities of daily living
were just simulated, without real goal or use of objects,
which may have interfered on the results. Although non-
dominant UL performance seems to be poorer than dominant
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limb performance, no studies compared the performance
of patients with DMD/BMD in real and goal-directed func-
tional activities (7).
Considering that scoliosis is frequent in DMD/BMD,
the convexity could be related to UL asymmetry (3). Addi-
tionally, a better understanding about UL performance and
possible symmetries or asymmetries between dominant
and non-dominant limbs could optimize evaluation and
clinical reasoning for interventions involving UL function in
DMD/BMD (7).
This study aimed to investigate possible differences
and relationships between the performances of dominant
and non-dominant ULs in daily living, goal-directed activ-
ities in patients with DMD/BMD. We hypothesized that dom-
inant and non-dominant ULs would exhibit significantly
different performances. Also, we aimed to compare patients
with normative data from the literature of gender- and
age-matched healthy controls. We hypothesized that UL
asymmetry would be higher in patients with DMD/BMD
than in healthy controls, because patients show many
compensatory movements.
As a secondary objective, we aimed to investigate
the relationship of UL timed performance and age, motor
function and muscle strength in DMD/BMD patients. We
hypothesized that these variables would be related in
DMD/BMD patients and that the asymmetry would be less
evident in initial DMD/BMD (younger patients) than in severe
cases (older patients).
Material and Methods
The study was approved by the Federal University of
São Paulo Ethics Committee (process No. 132-193). This is a
prospective observational study with cross-sectional design.
Subjects
All patients from the Brazilian Association of Muscular
Dystrophy (ABDIM) with non-normal levels of dystrophin
detected by DNA analysis were recruited to participate.
The inclusion criterion was the confirmation of absence
(in DMD) or decreased levels (in BMD) of dystrophin,
which is a biomarker of a genetic error on Xp21 (8). Forty-
three patients gave informed consent to participate.
Ten patients were excluded due to time unavailability.
Seven patients were excluded because they could not grasp
objects. Seven patients were excluded due to difficulty under-
standing the tasks, caused by severe cognitive impair-
ment, detected by the Mini-Mental State Examination
(MMSE) (9). In a previous pilot study, we observed that
a cut-off of ten points (instead of eighteen) could be
considered for these patients, because they could perform
all Jebsen-Taylor and Motor Function Measure tasks. All
patients included in the study were able to understand the
tasks (10).
The patients, parents or legal guardians signed the
informed consent form prior to participation. Sixteen patients
with DMD (aged 16.8±3.9 years) and 3 with BMD (aged
26.0±1.7 years) were evaluated. All patients scored 7 or 8
on the Vignos Scale (11) and used wrist orthosis during
the night.
Procedures
Lower extremity function was classified by the Vignos
Scale (11). The scores range from 1 to 10, with 1 meaning
that the subject can walk and climb stairs without assis-
tance, and 10 meaning that the subject is confined to
a bed.
Upper extremity function was classified by the Brooke
Scale (12). This scale ranges from 0 to 6, with 1 meaning
that the patient is able to abduct the shoulder in 180 degrees
and 6 meaning that the patient has no useful function of
the UL.
Dominance was determined by asking and observing
the preferred hand during the manipulation of everyday
objects, such as scissors, comb, toothbrush and pencil (13).
Muscle strength of shoulders (flexors, extensors, abduc-
tors, adductors, internal and external rotators), elbows (flexors,
extensors, supinators and pronators) and wrists (flexors
and extensors) were tested by the Medical Research
Council (MRC) Scale (14). To test muscle groups, manual
resistance was applied with the patient lying on dorsal,
ventral, and lateral decubitus, and on sitting position. The
score was graded from 0 to 5, with 0 indicating no muscle
contraction and 5 indicating normal strength (15). We adopted
the MRC index (14) to calculate the percentage of muscle
strength according to proximal (shoulder) or distal (elbow
and wrist) location.
Spinal deformity was evaluated by asking the patient
to lean forward with support if necessary (16). The side
(right or left) and curve convexity were registered.
All patients were assessed with the Jebsen-Taylor Test
(JTT) (17,18) and Dimension 3 of Motor Function Measure
(MFM D3) (19–21). Each patient was positioned on his
own wheelchair or in a height-adjustable chair, which
allowed the correct positioning of hips, knees and ankles,
flexed at approximately 90°. A table with adjustable height
was used. Each subtest was conducted after making sure
the patient had understood the task.
JTT has seven subtests (1: writing; 2: turning over
cards; 3: picking up small common objects; 4: simulating
feeding; 5: stacking checkers; 6: picking up large light
objects; 7: picking up large heavy objects). All subtests
have gender- and age-matched normative values for people
between 15 and 25 years old in order to compare timed
performances (22). Subtest 7 was excluded because
patients with DMD/BMD have difficulty carrying heavy
objects. Subtests 1, 2, 3, 4, 5, and 6 were performed in
sequence, first with the non-dominant UL and then with
the dominant UL, according to Jebsen-Taylor standard
instructions (17). The time of all attempts was measured in
seconds (s) using a stopwatch (17,18). When a patient
was not able to complete a JTT subtest due to motor
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difficulties, the score was registered as the highest time on
the subtest plus 20%.
MFM D3 consists of seven items to evaluate distal
motor function. The scoring of each item uses a 4-point
scale (from 0 to 3). Zero means that the patient cannot
initiate the task or cannot maintain the starting position
and 3 means the patient is able to complete the task with
the standard pattern. The total score is reported as a
percentage of the maximum possible score (19–21).
Data analysis
Data showed homoscedasticity (tested by Levene Test)
and normal distribution (tested by Kolmogorov-Smirnov
Test). Analyses of variance (two-way ANOVAs) compared
dominant and non-dominant UL timed performances.
When post hoc analyses were necessary, Tukey tests
were run. The relationships between dominant and non-
dominant UL performances and JTT, MFM D3 and MRC
scores were tested by Pearson correlation tests. The cor-
relation coefficients (r) were considered strong when
rX0.70 and moderate when 0.704rX0.40 (23).
In order to investigate UL asymmetry in JTT subtests,
patients were compared to normative data. A dominance
index (the mean time of the dominant UL divided by the mean
time of the non-dominant UL) was calculated, which repre-
sents UL symmetry. Values near zero indicate UL asymmetry
and values near one indicate UL symmetry. The comparison
between two proportions was done with the chi-square test.
The relationships between the dominance indexes and age
were tested by Spearman correlation tests (23).
Statistical analysis was performed using the Statistica
software version 13.0 (Statsoft, USA). The level of signifi-
cance was set at 5%.
Results
Clinical characteristics
Sample characteristics are displayed in Table 1. Vignos
scores ranged from 1 to 8 and Brooke scores ranged from
1 to 5. About 90% (n=17) of patients exhibited right UL
dominance. The median of the percentages of proximal
muscle strength and distal muscle strength were 50
and 66%, respectively. Most patients (n=10; 52.6%) showed
thoracolumbar scoliosis, 5 patients (26.3%) showed
lumbar scoliosis, 1 (5.3%) showed thoracic scoliosis
and 3 (15.8%) did not show scoliosis. All patients under-
stood and performed all tests without referring pain, fatigue
or discomfort.













1 13 28 1 1 80/97% DMD R Absent
2 16 28 8 3 47/62% DMD R Thoracolumbar R
3 20 28 8 5 27/57% DMD R Thoracolumbar R
4 16 28 8 3 43/53% DMD R Thoracolumbar L
5 28 28 2 1 87/87% BMD R Absent
6 17 26 7 3 50/80% DMD L Thoracolumbar R
7 18 27 8 3 50/63% DMD L Thoracolumbar L
8 25 21 8 3 47/70% BMD R Lumbar L
9 24 16 7 3 47/63% DMD R Thoracolumbar L
10 11 13 1 1 83/82% DMD R Absent
11 20 15 8 5 33/50% DMD R Lumbar L
12 13 30 2 1 70/80% DMD R Thoracolumbar R
13 25 28 6 3 60/62% BMD R Thoracolumbar L
14 13 24 3 2 63/97% DMD R Thoracic R
15 15 30 7 3 50/65% DMD R Lumbar R
16 16 12 8 3 60/60% DMD R Thoracolumbar R
17 23 27 7 4 30/57% DMD R Lumbar L
18 21 29 7 3 50/85% DMD R Lumbar R




















11–28 11–30 1–8 1–5 27–87%/
50–97%
– – –
DMD/BMD: Duchenne and Becker muscular dystrophies; MMSE: Mini-Mental State Examination; R: right; L: left.
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Comparison between dominant and non-dominant UL
performance on JTT subtests
Repeated measures ANOVA showed an effect of JTT
subtest (F5,90=17.167; Po0.001; ES=0.488), an effect of
UL (F1,18=15.444; Po0.001; ES=0.462) and an interac-
tion between subtest and UL (F5,90=10.433; Po0.001;
ES=0.367). Post hoc Tukey tests showed a significant
difference between non-dominant and dominant UL only
in subtest 1 (Po0.001; Figure 1).
No significant differences between patients and con-
trols (normative data) were found in the dominance
indexes of JTT subtests (Table 2).
Figure 1. Repeated measures analysis of var-
iance reported as means and 95% confidence
intervals for each subtest of Jebsen-Taylor Test,
comparing non-dominant (ND) and dominant (D)
upper limbs. There was an interaction between
subtest and limb (Po0.001) and post hoc Tukey
tests showed a significant difference between ND
and D upper limbs (Po0.001) only in subtest 1.
Table 2. Comparison between dominance index of healthy subjects and Duchenne and Becker muscular
dystrophies (DMD/BMD) patients, based on Jebsen-Taylor subtests.
Subtest/Dominance Healthy subjects DMD/BMD patients P
Mean time Dominance index Mean time Dominance index
1
NDUL 20.06 0.414 88.47 0.541 0.193
DUL 8.31 47.89
2
NDUL 6.47 0.912 11.33 0.986 0.142
DUL 5.9 11.17
3
NDUL 6.85 0.873 27.48 0.832 0.345
DUL 5.98 22.86
4
NDUL 7.29 0.809 45.03 0.815 0.479
DUL 5.9 36.69
5
NDUL 3.75 0.885 9.99 0.818 0.256
DUL 3.32 8.17
6
NDUL 4.14 0.855 19.56 0.739 0.155
DUL 3.54 14.45
NDUL: non-dominant upper limb; DUL: dominant upper limb. P40.05, ANOVA.
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Correlations between dominant and non-dominant UL
performances on JTT
Strong positive correlations were found between non-
dominant and dominant UL in all JTT subtests (Table 3).
Many strong relationships were found between the perfor-
mances of dominant and non-dominant UL in subtests 2,
3, 4, 5, and 6 (Table 3).
Correlation between muscle strength (MRC), JTT and
MFM scores
Vignos score strongly correlated to proximal (r=
–0.847; Po0.001) and distal muscle strength (r=–0.790;
Po0.001). Proximal muscle strength strongly correlated
to subtest 6 performed by non-dominant UL (r=–0.767;
Po0.001) and to distal muscle strength (r=0.777; Po
0.001). Distal muscle strength strongly correlated to sub-
tests 3 and 6, performed by the dominant UL (r=–0.717
and r=–0.709, respectively; Po0.001). MFM D3 strongly
correlated to subtest 6, performed by the dominant UL
(r=–0.709; Po0.001) (Table 4).
Discussion
The present study investigated possible differences
and relationships between the performances of dominant
and non-dominant ULs on daily life, goal-directed activities
of patients with DMD/BMD with normative data of healthy
controls. The clinical heterogeneity of our sample was
expected. We believe this phenotypic variability is impor-
tant to represent the whole spectrum of UL dysfunctions
observed in DMD/DMB forms and stages.
First, we hypothesized that dominant and non-dominant
ULs would exhibit significantly different performances. Our
results showed that this occurred only with JTT subtest 1,
which was a writing task. The writing subtest was signifi-
cantly faster with the dominant UL in patients and controls.
This ability involves much more unilateral coordination
than the other tasks (22). This difference between UL
performances was not observed in the other five JTT sub-
tests (2: turning over cards; 3: picking up small common
objects; 4: simulating feeding; 5: stacking checkers; 6:
picking up large light objects).
UL performance of DMD patients has been studied by
Janssen et al. (6). They assessed the maximal voluntary
isometric contraction of biceps brachii, anterior deltoid
and lateral deltoid muscles, single joint movements of
elbow flexion/extension and pronation/supination, shoulder
abduction/adduction, flexion/extension, internal/external
rotation and the simulation of reaching forward, touching
contralateral shoulder, combing hair and bringing the hand
to the mouth (6). No significant differences were found
between left and right UL movements considering muscle
activation. However, the authors worked with open-loop
situations that have much higher predictability than the
present study. In our study, patients had to deal with
closed-loop tasks (24). Considering subtest 4 (simulating
feeding) as an example, the task requires motor repro-
gramming during the attempts of holding a spoon, picking
up the beans, transporting and depositing them in a bowl.
The result of action is continually considered for move-
ment corrections during the task. JTT protocol involves
real goals instead of only simulating the tasks, which
results in higher muscular demand (25).
Second, we hypothesized that UL asymmetry would
be less evident in initial cases of dystrophinopathies (younger
patients) and more evident in severe cases (older patients).
This hypothesis was not confirmed by our results. Although
we included wide ranges for age and Vignos scores, no
correlations between age, dominance index and timed
performance were observed.
We also hypothesized that UL asymmetry would be
higher in patients with DMD/BMD than in healthy controls,
due to the compensatory movements employed to perform
functional tasks. The dominance indexes showed that
Table 3. Correlations between times of subtests of Jebsen-Taylor Test performed by dominant and non-dominant upper limbs.
1 ND 1 D 2 ND 2 D 3 ND 3 D 4 ND 4 D 5 ND 5 D 6 ND 6 D
1 ND – – – – – – – – – – – –
1 D 0.948 – – – – – – – – – – –
2 ND 0.371 – – – – – – – – – – –
2 D – 0.228 0.869 – – – – – – – – –
3 ND 0.085 – 0.889 – – – – – – – – –
3 D – 0.394 – 0.713 0.713 – – – – – – –
4 ND 0.141 – 0.760 – 0.837 – – – – – – –
4 D – 0.104 – 0.743 – 0.606 0.773 – – – – –
5 ND 0.011 – 0.867 – 0.968 – 0.803 – – – – –
5 D – 0.112 – 0.949 – 0.661 – 0.808 0.851 – – –
6 ND 0.174 – 0.864 – 0.922 – 0.835 – 0.867 – – –
6 D – 0.525 – 0.839 – 0.856 – 0.728 – 0.775 0.830 –
D: dominant upper limb; ND: non-dominant upper limb. Values in bold: Po0.05 (Spearman).
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patients with DMD/BMD are not more asymmetrical than
gender- and age-matched healthy controls. The dominance
index was developed to elucidate how much slower the
non-dominant limb would be than the dominant limb, and
therefore, how asymmetric patients would be. The indexes
close to 1 represent the absence of asymmetry in timed
performance of UL of patients and healthy controls. Further-
more, the dominance index was not correlated with age or
Vignos score, showing that it is independent of disease
stage.
We observed that the performances of ULs were
consistently correlated in patients. This relationship can
be explained by the existence of motor equivalence, which
is part of the central motor program theory (26). This
theory states that limbs move together, as a unit, due to a
unique central motor program, which controls all action
parameters. Besides, one limb activity can prevail over the
other. Therefore, the non-dominant can move to assist the
dominant UL. Interestingly, we found the same pattern in
patients with DMD/DMB.
We found many correlations between proximal and
distal muscle strength and timed performance on JTT
tasks. Lower proximal and distal muscle strength denotes
higher times on JTTsubtests. Also, JTT times of dominant
and non-dominant ULs were correlated to each other and
many of them were also correlated to MFM. JTT and
MFM represent different ways of assessing UL function in
DMD/BMD patients. Dimension 3 of MFM assesses the
quality of distal UL movements, with only one timed task,
and JTTassesses timed performance, but both tests require
dexterity and represent motor function. Nunes et al.
(2016) found a relationship between motor function
and muscular strength measured by MFM and manual
testing, respectively, in patients with DMD. The present
study expands this knowledge, establishing the relation-
ship between timed performance, motor function and
muscular strength.
Scoliosis is usually secondary to muscle weakness
and part of the natural history of DMD (27), with higher
prevalence among more severe cases (28,29). The impact
of scoliosis on UL function was poorly studied in the liter-
ature. Patients with good trunk stability can perform UL
functions without support. Contrarily, patients with poor
trunk stability need trunk support to perform UL tasks.
A recent study (30) related the occurrence of scoliosis
with poor UL function, due to the impairment of sitting
balance. Therefore, reduced sitting balance has a nega-
tive influence on UL function (31,32). Besides, it seems
that the side scoliosis is not related to UL dominance,
although the non-dominant UL is more frequently observed
Table 4. Correlations (r) between proximal and distal upper limb muscle strength, subtests of Jebsen-Taylor Test, and scores of
dimension 3 of Motor Function Measure (MFM D3).
Vignos score Age Proximal muscle strength Distal muscle strength MFM D3
Subtest 1 ND 0.099 –0.248 –0.043 –0.117 –0.117
Subtest 1 D 0.176 –0.221 –0.054 –0.147 –0.147
Dominance index 1 0.193 –0.272 –0.033 0.066 0.066
Subtest 2 ND 0.483 0.154 –0.621 –0.621 –0.578
Subtest 2 D 0.368 0.188 –0.555 –0.571 –0.529
Dominance index 2 0.168 0.070 –0.181 0.013 0.013
Subtest 3 ND 0.302 0.197 –0.602 –0.531 –0.461
Subtest 3 D 0.420 0.060 –0.585 –0.715 –0.498
Dominance index 3 0.195 –0.118 0.103 –0.099 –0.099
Subtest 4 ND 0.354 0.074 –0.575 –0.494 –0.483
Subtest 4 D 0.376 0.037 –0.570 –0.579 –0.366
Dominance index 4 0.084 0.168 –0.092 –0.113 –0.097
Subtest 5 ND 0.321 0.225 –0.523 –0.457 –0.330
Subtest 5 D 0.377 0.088 –0.585 –0.626 –0.484
Dominance index 5 0.231 –0.395 –0.536 –0.464 –0.276
Subtest 6 ND 0.442 0.212 –0.767 –0.678 –0.422
Subtest 6 D 0.511 0.087 –0.649 –0.709 –0.709
Dominance index 6 –0.192 –0.110 0.357 0.186 –0.276
Vignos score – 0.296 –0.847 –0.790 –0.408
Age 0.296 – –0.255 –0.232 0.289
Proximal muscle strength –0.847 –0.255 – 0.777 0.304
Distal muscle strength –0.790 –0.232 0.777 – 0.528
Motor function measure D3 –0.408 0.289 0.304 0.528 –
ND: non-dominant; D: dominant. Values in bold: Po0.05 (Pearson).
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as a support for the non-aligned trunk side. Scoliosis
convexity did not coincide with UL dominance.
Cognitive impairment is common in boys with DMD/
BMD (33). Therefore, feasible tests must be developed,
considering this characteristic. In a previous pilot study (10),
we verified that in patients aged 10 to 30 years, MMSE
scores were correlated to scores of cognitive tests
(verbal fluency, clock drawing, and digits - direct and
inverse orders). That study showed that patients scoring
11 or higher in MMSE can perform all JTT and MFM
subtests. We observed that cognitive impairment did
not interfere with the comprehension of simple verbal
commands. However, lower MMSE scores were obtained
in individuals with lower motor performance on JTT and
MFM. Patients with better cognitive function may select
more efficient motor synergies to overcome muscular
weakness.
The findings provide relevant information for clinical
practice. First, this assessment battery did not show any
symptoms of overuse of dominant UL or disuse of non-
dominant UL and can be considered safe. Second,
as dominant and non-dominant UL performances were
correlated, the assessment protocol can be performed
with only one UL, to eliminate redundancy. It may reduce
assessment time and prevent fatigue. Third, this assess-
ment protocol evaluates two different and relevant fea-
tures of UL function: timed performance (JTT) and UL
movements (MFM D3).
Future studies could describe the compensatory
movements performed by patients with DMD/BMD, not
only on limbs, but also trunk movements, which contribute
to a better performance of UL functions. Trunk move-
ments may have helped on some JTT tasks. Besides, the
investigation between limbs and trunk strength, and timed
performed data may add information for better under-
stand the performance of patients with DMD/BMD. These
findings will optimize clinical intervention approaches to
preserve muscle activation and UL function.
In conclusion, UL performance was only asymmetrical
in the writing test, but not in other UL tasks. Dominant and
non-dominant UL performances were correlated on daily
life, goal-directed activities of patients with DMD/BMD.
Gender- and age-matched healthy controls were not more
asymmetrical than patients. Asymmetry was not more
evident in more severe cases (older patients) than in less
severe cases (younger patients). Correlations between
timed performance, motor function and muscle strength
were found, but age was not correlated to these variables.
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